Alpha DNA Investment Management’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,601
Closed -$768K 171
2023
Q2
$768K Buy
+8,601
New +$768K 0.26% 111